Kazia Therapeutics
KZIA
13 hedge funds and large institutions have $4.12M invested in Kazia Therapeutics in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
78% more capital invested
Capital invested by funds: $2.31M → $4.12M (+$1.8M)
18% more funds holding
Funds holding: 11 → 13 (+2)
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Atom Investors
Austin,
Texas
|
+$791K |
| 2 |
Morgan Stanley
New York
|
+$229K |
| 3 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$156K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$28.3K |
| 5 |
Renaissance Technologies
New York
|
+$16.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Truist Financial
Charlotte,
North Carolina
|
-$234K |
| 2 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$47.9K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $1.55M | +$229K | +574 | +19% |
|
|
AI
2
Atom Investors
Austin,
Texas
| $857K | +$791K | +1,984 | New |
|
|
3
Renaissance Technologies
New York
| $688K | +$16.7K | +42 | +3% |
|
|
HAG
4
HighPoint Advisor Group
Downers Grove,
Illinois
| $368K | -$47.9K | -120 | -16% |
|
|
5
Truist Financial
Charlotte,
North Carolina
| $304K | -$234K | -587 | -45% |
|
|
SFI
6
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $170K | +$156K | +392 | New |
|
|
TW
7
Transform Wealth
Greenwood Village,
Colorado
| $95K | – | – | – |
|
|
8
Simplex Trading
Chicago,
Illinois
| $30K | +$28.3K | +71 | New |
|
9
UBS Group
Zurich,
Switzerland
| $25K | +$12.4K | +31 | +119% |
|
10
Wells Fargo
San Francisco,
California
| $24K | +$6.38K | +16 | +40% |
|
|
CG
11
Cutler Group
San Francisco,
California
| $3K | +$3.19K | +8 | New |
|
|
SPIA
12
Steward Partners Investment Advisory
New York
| $1K | – | – | – |
|
|
RE
13
RBC Europe
London,
United Kingdom
| $276 | – | – | – |
|
|
14
Acadian Asset Management
Boston,
Massachusetts
| – | -$6K | -19 | Closed |
|
KZIA Hedge Fund Activity: Q4 2020 in Review
13 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q4 2020, worth a combined $4.12M — up 78% from $2.31M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new KZIA positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Atom Investors, opening a new position worth an estimated $791K. The largest seller was Truist Financial, cutting an estimated $234K.
- 13 institutional investors held Kazia Therapeutics (KZIA) as of Q4 2020, up from 11 in Q3 2020.
- Funds reported $4.12M of Kazia Therapeutics stock for Q4 2020, up 78% quarter-over-quarter.
- 4 funds opened new Kazia Therapeutics positions in Q4 2020 and 2 closed out, a net change of +2 holders.
- The largest Kazia Therapeutics buyer in Q4 2020 was Atom Investors, an estimated $791K added.
- The largest Kazia Therapeutics seller in Q4 2020 was Truist Financial, an estimated $234K sold.
Based on aggregated 13F filings for Q4 2020.